Carlisle Companies Incorporated (CSL)

Debt-to-equity ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Long-term debt US$ in thousands 1,886,700 2,281,100 2,575,400 2,080,200 1,341,400
Total stockholders’ equity US$ in thousands 2,829,000 3,024,400 2,629,500 2,537,700 2,642,800
Debt-to-equity ratio 0.67 0.75 0.98 0.82 0.51

December 31, 2023 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $1,886,700K ÷ $2,829,000K
= 0.67

The debt-to-equity ratio of Carlisle Companies Inc. has fluctuated over the past five years, ranging from 0.60 in 2019 to 1.11 in 2021. A lower ratio indicates less reliance on debt to finance operations, while a higher ratio suggests higher debt levels relative to equity.

In 2019, the company had a relatively low debt-to-equity ratio of 0.60, indicating a conservative approach to leverage. However, there was a significant increase in 2021, with the ratio jumping to 1.11, signaling a higher level of debt relative to equity. This could be a result of increased borrowing or declining equity levels during that period.

The ratio decreased to 0.82 in 2020 before slightly increasing to 0.85 in 2022 and further dropping to 0.81 in 2023. These fluctuations suggest potential changes in the company's capital structure and financing decisions over the years.

Overall, the trend in Carlisle Companies Inc.'s debt-to-equity ratio indicates some variability in its capital structure and financial leverage. It would be important to further investigate the factors driving these changes and assess the company's ability to manage its debt levels effectively.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-equity ratio
Carlisle Companies Incorporated
CSL
0.67
West Pharmaceutical Services Inc
WST
0.03